Saurabh Saha, CEO: Centessa Pharmaceuticals CNTA Sell · Filed 25/02/20

Trade details

Type: Insider sale
Amount: $863,262
Shares · price: 54,225 sh · $15.92 a share
Held after: 331,792 sh
Stock: Centessa Pharmaceuticals CNTA
Person: Saurabh SahaCEO
Trade date: 25/02/20
Filed: 25/02/20
Days to filing: 0 days

Sold 14.0% of holdings

Share of holding sold: 14.0%

Centessa Pharmaceuticals trades, last 26 weeks

What else happened in Centessa Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/21~25/03/22

Saurabh Saha's recent trades

Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$875.6K
55,000 sh
$875.6K
Filed 25/07/21
Traded 25/07/21
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$694.7K
55,000 sh
$694.7K
Filed 25/06/20
Traded 25/06/20
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$699.1K
55,000 sh
$699.1K
Filed 25/05/20
Traded 25/05/20
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$501.5K
40,344 sh
$501.5K
Filed 25/04/22
Traded 25/04/22
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$180.1K
14,656 sh
$180.1K
Filed 25/04/22
Traded 25/04/21

Saurabh Saha, CEO — sold $863.3K of Centessa Pharmaceuticals CNTA · 14.0% of holdings · 10b5-1 plan | Whalegun